Financhill
Sell
28

CTXR Quote, Financials, Valuation and Earnings

Last price:
$3.55
Seasonality move :
20.84%
Day range:
$3.38 - $3.73
52-week range:
$2.44 - $26.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.39x
Volume:
109K
Avg. volume:
182.5K
1-year change:
-81.01%
Market cap:
$27.5M
Revenue:
--
EPS (TTM):
-$5.97

Earnings Data

Next earnings date for CTXR
Feb 14
2025
Most recent earnings per share
-$1.72
Missed by $0.22
(Dec 27/2024)
Consensus Estimate
-$1.50
(Dec 27/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CTXR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 $2.7M -- -- -$1.25 --
02/14/2025 Q4 -- -- -- -$1.25 --
12/27/2024 Q3 -- -- -$1.72 -$1.50 -$0.22
08/12/2024 Q2 -- -- -$1.50 -$1.13 -$0.38
05/14/2024 Q1 -- -- -$1.25 -$1.50 $0.25
02/14/2024 Q4 -- -- -$1.50 -- --
09/30/2023 Q3 -- -- -$1.75 -$1.50 -$0.25
08/14/2023 Q2 -- -- -$1.50 -$1.75 $0.25
05/12/2023 Q1 -- -- -$1.75 -$1.25 -$0.50
02/10/2023 Q4 -- -- -$0.50 -- --
09/30/2022 Q3 -- -- -$1.25 -$1.50 $0.25
08/11/2022 Q2 -- -- -$1.50 -- --
05/12/2022 Q1 -- -- -$1.25 -- --
02/10/2022 Q4 -- -- -$1.50 -- --
12/16/2021 Q3 -- -- -$0.75 -- --
08/12/2021 Q2 -- -- -$1.25 -- --
05/13/2021 Q1 -- -- -$1.00 -- --
02/11/2021 Q4 -- -- -$3.75 -- --
12/16/2020 Q3 -- -- -$1.75 -- --
08/14/2020 Q2 -- -- -$2.75 -- --
05/14/2020 Q1 -- -- -$3.25 -- --
12/31/2019 Q4 -- -- -$3.75 -- --
09/30/2019 Q3 -- -- -$4.00 -- --
06/30/2019 Q2 -- -- -$5.00 -- --
03/31/2019 Q1 -- -- -$5.00 -- --
12/31/2018 Q4 -- -- -$5.50 -- --
09/30/2018 Q3 -- -- -$4.50 -- --
06/30/2018 Q2 -- -- -$4.75 -- --
03/31/2018 Q1 -- -- -$11.00 -- --
12/31/2017 Q4 -- -- -$9.50 -- --
09/30/2017 Q3 -- -- -$10.50 -- --
06/30/2017 Q2 -- -- -$12.00 -- --
03/31/2017 Q1 -- -- -$13.75 -- --
12/31/2016 Q4 -- -- -$11.00 -- --
09/30/2016 Q3 -- -- -$12.75 -- --
06/30/2016 Q2 -- -- -$18.75 -- --
03/31/2016 Q1 -- -- -$7.50 -- --
12/31/2015 Q4 -- -- -$15.00 -- --
09/30/2015 Q3 -- -- -$11.75 -- --
06/30/2015 Q2 -- -- -$11.25 -- --
03/31/2015 Q1 -- -- -$3.75 -- --

Citius Pharmaceuticals Earnings Questions

  • How Much did Citius Pharmaceuticals Generate in Revenue Last Quarter?

    Citius Pharmaceuticals reported -- worth of top line sales in its most recent quarter.

  • Did Citius Pharmaceuticals Beat Earnings Last Quarter?

    Citius Pharmaceuticals announced earnings per share of -$1.72 which represents a miss of analyst forecast a -$1.50 per share.

  • Is Citius Pharmaceuticals Profitable?

    Citius Pharmaceuticals reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Citius Pharmaceuticals EPS Next Year?

    Citius Pharmaceuticals's earnings are forecast to decrease from -$5.97 per share to -$5.63 per share next year representing a decrease of -0.99%.

  • When is Citius Pharmaceuticals's Earnings Date?

    Citius Pharmaceuticals's next earnings date is February 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Target a Dividend King?
Is Target a Dividend King?

Popular retail giant Target Corporation (NYSE:TGT) has been in a…

Is COWZ ETF a Good Investment?
Is COWZ ETF a Good Investment?

There’s a reason even Warren Buffett advocates his heirs to…

3 Stocks Buffett Is Betting On
3 Stocks Buffett Is Betting On

Warren Buffett appeared to take a hard look at the…

Stock Ideas

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 38x

Sell
44
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 110x

Sell
40
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Buy
72
HEES alert for Jan 15

H&E Equipment Services [HEES] is up 105.42% over the past day.

Sell
26
SIG alert for Jan 15

Signet Jewelers [SIG] is down 21.66% over the past day.

Sell
45
WGS alert for Jan 15

GeneDx Holdings [WGS] is down 15.3% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock